Rivier C, Rivest S
Clayton Foundation Laboratories for Peptide Biology, Salk Institute, San Diego, CA 92128.
Ciba Found Symp. 1993;172:204-20; discussion 220-5. doi: 10.1002/9780470514368.ch10.
Exposure to an antigen causes significant endocrine changes, some of which in turn affect immune functioning. Proteins produced by activated immune cells, cytokines, act as messengers between the immune and the endocrine systems, and convey to the brain the occurrence of immune activation. We have investigated the ability of interleukin 1 (IL-1) alpha and beta to alter endocrine functioning in the adult rat. Acute peripheral injection of IL-1 alpha or beta causes dose-dependent increases in plasma adrenocorticotropic hormone (ACTH) and corticosterone secretion. These changes are primarily dependent upon increased release of corticotropin-releasing factor (CRF) into the portal circulation, and recent studies have indicated that the paraventricular nucleus (PVN) of the hypothalamus is the main source of this CRF. This conclusion is based on our finding that intravenous injection of IL-1 increases CRF biosynthesis in the PVN, and that lesion of this hypothalamic area interferes with IL-1's stimulatory action on ACTH secretion. Indomethacin partially reverses the effect of IL-1, suggesting that increased prostaglandin synthesis plays some part in this activation. Administration of IL-1 beta into the brain, but not into the general circulation, interferes with secretion of luteinizing hormone (LH) and ovulation through mechanisms involving endogenous opiates. Because neither CRF antagonists, nor lesions of the PVN, alter the inhibitory effect of IL-1 on LH release, CRF perikarya in the PVN do not appear to be involved in this phenomenon. Central administration of IL-1 beta strongly increases c-Fos immunoreactivity in the PVN, mainly within CRF neurons. Infusion of IL-1 beta into the PVN does not induce measurable changes in release of gonadotropin-releasing hormone (GnRH), but infusion of IL-1 directly into the median preoptic area (MPOA), a region rich in GnRH perikarya, markedly decreases GnRH secretion in rats bearing a push-pull cannula in the median eminence. Furthermore, central administration of IL-1 beta during the critical phase of pro-oestrus (1600-1930) also inhibits the expression of c-fos in GnRH cell bodies in the MPOA. Thus, we suggest that IL-1 interferes with reproductive functioning through a direct action at the level of the MPOA. These results indicate that circulating cytokines can alter the activity of the hypothalamo-pituitary-adrenal axis by increasing CRF release, probably through both immediate stimulation of CRF terminals within the median eminence and stimulation of CRF synthesis in the PVN. In contrast, cytokine-induced changes in LH and GnRH secretion are mediated through pathways lying primarily beyond the blood-brain barrier.
接触抗原会引起显著的内分泌变化,其中一些变化反过来又会影响免疫功能。活化免疫细胞产生的蛋白质——细胞因子,充当免疫和内分泌系统之间的信使,并将免疫激活的情况传递给大脑。我们研究了白细胞介素1(IL-1)α和β改变成年大鼠内分泌功能的能力。急性外周注射IL-1α或β会导致血浆促肾上腺皮质激素(ACTH)和皮质酮分泌呈剂量依赖性增加。这些变化主要依赖于促肾上腺皮质激素释放因子(CRF)向门脉循环的释放增加,最近的研究表明下丘脑室旁核(PVN)是这种CRF的主要来源。这一结论基于我们的发现,即静脉注射IL-1会增加PVN中CRF的生物合成,并且该下丘脑区域的损伤会干扰IL-1对ACTH分泌的刺激作用。吲哚美辛部分逆转了IL-1的作用,表明前列腺素合成增加在这种激活中起了一定作用。将IL-1β注入脑内而非全身循环,会通过涉及内源性阿片类物质的机制干扰促黄体生成素(LH)的分泌和排卵。由于CRF拮抗剂和PVN损伤均未改变IL-1对LH释放的抑制作用,PVN中的CRF神经元胞体似乎不参与这一现象。脑室内注射IL-1β会强烈增加PVN中的c-Fos免疫反应性,主要在CRF神经元内。向PVN注入IL-1β不会引起促性腺激素释放激素(GnRH)释放的可测量变化,但将IL-1直接注入富含GnRH神经元胞体的视前正中区(MPOA),会显著降低在正中隆起处植入推挽式套管的大鼠的GnRH分泌。此外,在动情前期关键阶段(1600 - 1930)脑室内注射IL-1β也会抑制MPOA中GnRH细胞体中c-fos的表达。因此,我们认为IL-1通过在MPOA水平的直接作用干扰生殖功能。这些结果表明,循环中的细胞因子可能通过直接刺激正中隆起内的CRF终末和刺激PVN中CRF的合成,增加CRF释放,从而改变下丘脑 - 垂体 - 肾上腺轴的活性。相比之下,细胞因子诱导的LH和GnRH分泌变化主要通过位于血脑屏障之外的途径介导。